General Capital (GEN:NZ) subsidiary General Finance update

General Capital (GEN:NZ) subsidiary General Finance update

General Capital Limited advises that its subsidiary General Finance Limited, a licensed Non-bank Deposit Taker, has uploaded its quarterly unaudited report for the quarter ended 30 June 2023 to the Disclose Register.

Mr. Brent King, Managing Director, explained that this report is required as General Finance Limited holds a Non-bank Deposit Taker licence and the reporting is a requirement of the Financial

Markets Conduct Act 2013.

The information can be found at www.disclose-register.companiesoffice.govt.nz.

ENDS

This announcement was authorized by Brent King, Managing Director

For further information contact:

Brent King Managing Director

General Capital Limited

+64 21 632 660

Brent.King@gencap.co.nz

14 August 2023

• General Capital subsidiary General Finance Update
•  GFL Disclose Quarterly Report 30 June 2023

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

Devon Funds Morning Note - 04 May 2026
MEL - Meridian joins global ranks of sustainable companies
May 5th Morning Report
ATM - a2MC recalls small volume of a2 Platinum USA label
CEN - Contact Chair to retire this year, new Chair appointed
May 1st Morning Report
GTK - Gentrack's Veovo Acquires Dubai Technology Partners
SML - Additional information following Bright Dairy announcement
April 30th Morning Report
Rua Bioscience Market Update